Has Shefali Shah, MD received payments from drug or device companies?

Yes. Drug and device makers reported $471 in general payments to Shefali Shah, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shefali Shah, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shefali Shah, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shefali Shah, MD

Otolaryngology · Long Beach, NYNPI 1568484020

Payments from drug & device makers

$471in general payments, 2019–2025

Across 9 payments — averaging $52.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$452
Optinose US, Inc.$18

What the payments were for

Food & beverage$471100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	8	$452
Optinose US, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$471 in reported general payments places this provider in the 35th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York →

Medicare billing

Part B allowed, 2024

$404,356

Medicare patients

545

Services billed

4,676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
QnaslBeclomethasone Dipropionate	83	$24,121
Mometasone Furoate	185	$8,699
Azelastine Hcl	282	$6,815
Ipratropium Bromide	192	$5,368
Omeprazole	248	$2,156
Montelukast Sodium	198	$2,095
Methylprednisolone	99	$605
Fluticasone Propionate	15	$275
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	17	$126
Famotidine	11	$95
Clindamycin Hcl	12	$92

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Long Beach

Robert KellmanSyracuse$2.5M
Anthony DelsignoreNew York$966K
Roheen RaithathaNew York$882K
Dennis KrausNew York$524K
Ashutosh KackerNew York$387K
Lawrence LustigNew York$383K
Brett MilesNew York$368K
Alfred Marc IloretaNew York$342K
Nora PerkinsAlbany$315K
Gavin SetzenAlbany$299K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →